Holen Sie sich die Stockscreener-App
1.15
10.16%
-0.13
Handel nachbörslich:
1.14
-0.01
-0.87%
Schlusskurs vom Vortag:
$1.28
Offen:
$1.28
24-Stunden-Volumen:
700.78K
Relative Volume:
2.01
Marktkapitalisierung:
$103.35M
Einnahmen:
$2.24M
Nettoeinkommen (Verlust:
$-136.67M
KGV:
-0.53
EPS:
-2.17
Netto-Cashflow:
$-102.08M
1W Leistung:
-21.23%
1M Leistung:
-32.75%
6M Leistung:
-60.48%
1J Leistung:
-24.84%
1-Tages-Spanne:
$1.14
$1.28
1-Wochen-Bereich:
$1.14
$1.46
52-Wochen-Spanne:
$1.14
$5.51
Century Therapeutics Inc Stock (IPSC) Company Profile
Firmenname
Century Therapeutics Inc
Sektor
Branche
Telefon
215-981-4000
Adresse
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-12-27 | Eingeleitet | Chardan Capital Markets | Buy |
| 2022-10-31 | Eingeleitet | Guggenheim | Buy |
| 2022-10-10 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-05-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-05-12 | Eingeleitet | William Blair | Mkt Perform |
| 2021-07-13 | Eingeleitet | BofA Securities | Buy |
| 2021-07-13 | Eingeleitet | JP Morgan | Overweight |
| 2021-07-13 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Century Therapeutics Inc Aktie (IPSC) Neueste Nachrichten
We're A Little Worried About Century Therapeutics' (NASDAQ:IPSC) Cash Burn Rate - Yahoo Finance
Layoff Tracker: Marinus Cuts Employees After Disappointing Phase III Trial - BioSpace
electroCore (ECOR) Stock Jumps 11.7%: Will It Continue to Soar? - Yahoo Finance
Century Therapeutics, Inc. (NASDAQ:IPSC) Short Interest Up 6.4% in September - MarketBeat
As the Cell Therapy Market Eyes $48 Billion, Bayer Invests $215 Million in Century Therapeutics As Revealed... - WhaTech
Dimensional Fund Advisors LP Acquires New Shares in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Artiva, Century, others extend natural-killer autoimmune push - BioWorld Online
Ubiquiti Inc. (NYSE:UI) Shares Sold by Dimensional Fund Advisors LP - Defense World
American Century Companies Inc. Has $128,000 Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
American Century Companies Inc. Acquires 36,528 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World
American Century Companies Inc. Boosts Holdings in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World
American Century Companies Inc. Purchases Shares of 9,803 Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - Defense World
American Century Companies Inc. Increases Position in TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World
American Century Companies Inc. Cuts Holdings in Janux Therapeutics, Inc. (NASDAQ:JANX) - Defense World
American Century Companies Inc. Has $291,000 Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World
American Century Companies Inc. Decreases Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Sold by American Century Companies Inc. - MarketBeat
American Century Companies Inc. Increases Stock Position in Jasper Therapeutics, Inc. (NASDAQ:JSPR) - Defense World
American Century Companies Inc. Boosts Stake in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) - Defense World
American Century Companies Inc. Sells 36,820 Shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat
You might want to take a look at Century Therapeutics Inc (IPSC) now - SETE News
Market Watch: Century Therapeutics Inc (IPSC)’s Noteworthy Drop, Closing at 1.61 - The Dwinnex
American Century Companies Inc. Has $687,000 Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Regenerative Medicine Market to Reach $37.27 Billion by 2031, Driven by the Growing Number of New Regenerative Medicine Approvals and Consistent Advancements in the Regenerative Medicine SpaceExclusive Report by Meticulous Research - The Malaysian Reserve
Taking a Closer Look At Century Therapeutics Inc (IPSC) Following Its Recent Trade - Knox Daily
Odyssey Therapeutics Appoints Timothy P. Walbert and Ian F. Smith to its Board of Directors - citybiz
New Century Financial Group LLC Sells 349 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) - Defense World
What was Century Therapeutics Inc (IPSC)’s performance in the last session? - US Post News
Odyssey Therapeutics Appoints Biopharma Veterans Timothy P. Walbert and Ian F. Smith to its Board of Directors - Business Wire
Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Shares Sold by American Century Companies Inc. - Defense World
American Century Companies Inc. Has $797,000 Stock Position in Pliant Therapeutics, Inc. (NASDAQ:PLRX) - Defense World
American Century Companies Inc. Grows Position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - MarketBeat
American Century Companies Inc. Grows Position in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
American Century Companies Inc. Increases Stake in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - Defense World
Short Interest in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Drops By 14.6% - Defense World
Beam Therapeutics Inc. (NASDAQ:BEAM) Shares Bought by American Century Companies Inc. - MarketBeat
Century Therapeutics Announces Strategic Leadership Appointments - MSN
Century Therapeutics appoints new CFO and CSO By Investing.com - Investing.com Australia
Century names CFO, CSO - BioCentury
Century Therapeutics add two new members to its C-suite - The Business Journals
Century Therapeutics Appoint Morgan Conn, Ph.D., as CFO and Chad Cowan, Ph.D., as CSO - citybiz
Century Therapeutics (NASDAQ:IPSC) & BioAtla (NASDAQ:BCAB) Financial Comparison - Defense World
Century Therapeutics Appoints Morgan Conn as New CFO - TipRanks
Century Therapeutics Names Morgan Conn Chief Financial Officer - MarketWatch
Century Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Officer - The Manila Times
Century Therapeutics appoints new CFO and CSO - Investing.com
Century Therapeutics Strengthens Leadership Team with - GlobeNewswire
Century Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Officer - GlobeNewswire Inc.
Audioboom Group (LON:BOOM) Stock Crosses Below 200 Day Moving Average of $241.02 - Defense World
Aurora Investment Trust (LON:ARR) Share Price Passes Below 200 Day Moving Average of $252.88 - Defense World
American Century Companies Inc. Buys 23,170 Shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS) - Defense World
Finanzdaten der Century Therapeutics Inc-Aktie (IPSC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.11%
0.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):